摘要
目的比较阿德福韦酯(ADV)及替比夫定(L-DT)单药治疗慢性乙型肝炎和肝硬化患者对肾脏功能的影响。方法回顾性分析接受ADV(n=46)及L-DT(n=55)单药治疗的101名慢性乙型肝炎和肝硬化患者,比较治疗52周的血清肌酐(CR)、估算肾小球滤过率(eGFR)较基线的变化情况及eGFR≥90 ml.min-.11.73 m-2患者的比例。结果 52周时,ADV和L-DT组患者CR较基线变化平均值分别为+0.05和-0.12 mg/dl(ADV vs L-DT,P=0.000),未观察到CR较基线升高>0.50 mg/dl患者;eGFR较基线变化中位数分别为-4.09和+18.32 ml.min-.11.73 m-(2ADV vs L-DT,P=0.000);基线肾功能轻度受损(eGFR<90 ml.min-.11.73 m-2)的患者中,ADV组有37.50%(3/8)在52周时上升至大于90 ml.min-1.1.73 m-2,L-DT组有92.31%(12/13)上升至大于90 ml.min-.11.73 m-2;ADV组eGFR≥90 ml.min-.11.73 m-2患者比例由基线的82.61%降至52周的78.26%,而L-DT组eGFR≥90 ml.min-1.1.73 m-2患者比例由基线的76.36%升至52周的94.55%;两组不同eGFR水平患者的构成比在基线时无统计学差异(P=0.443),52周时有统计学差异(P=0.015)。结论 L-DT抗病毒治疗对于肾脏功能具有一定的保护作用,但具体机制不明,需要进一步研究。
Objective To evaluate the changes in the renal function of patients with chronic hepatitis B (CHB) receiving adefovir dipivoxil (ADV) or telbivudine (L-DT) monotherapy. Methods This retrospective analysis involved 101 patients with CHB and liver cirrhosis receiving either ADV or L-DT monotherapy for 52 weeks. Serum creatinine, estimates of glomerular filtration rate (eGFR), and the percentage of patients with eGFR≥90 ml. min1.1.73 m2 at week 52 were compared with the baseline data between the two groups. Results The mean changes of CR at week 52 from baseline were +0.05 mg/dl in ADV group and -0.12 mg/dl in L-DT group, showing a significant difference between the two groups (P=0.000). No patient was found to have an elevation of creatinine over 0.50 mg/dl. The median change of eGFR at week 52 from baseline differed significantly between ADV and L-DT groups (-4.09 vs+18.32 ml- min-1. 1.73 m^2, P=0.000). Ninety-two percent (12/13) of the patients with baseline eGFR〈90 ml. min-1.1.73 m^2 shifted to eGFR ≥90 ml. min-1.1.73 m^-2 after 52 weeks of L-DT treatment, as compared to 38% (3/8) in ADV group. The proportion of patients with eGFR≥90 ml. min^-1. 1.73 m2 in L-DT group increased from 76.36% (42/55) at baseline to 94.55% (52/55) at week 52, while that in ADV group decreased from 82.61% (38/46) at baseline to 78.26% (36/46). The constituent ratios of eGFR at different levels were similar at baseline (P=0.443) but significantly different at week 52 between the two groups (P=0.015). Conclusion L-DT treatment is associated with a renoprotective effect in patients with CHB, but the mechanism remains unclear.
出处
《南方医科大学学报》
CAS
CSCD
北大核心
2012年第6期826-829,共4页
Journal of Southern Medical University
基金
十二五国家科技重大专项(2012ZX10002003)~~
关键词
慢性乙型肝炎
肾功能
肾小球滤过率
阿德福韦酯
替比夫定
chronic hepatitis B
renal function
estimates of glomerular filtration rate
adefovir dipivoxil
telbivudine